2024 Conference Publication Nontuberculous mycobacteria (NTM) in Australians with cystic fibrosis (CF): A national studyDuplancic, Christine, Wainwright, Claire, Thomson, Rachel, Rogers, Geraint, Clements, Archie, Floto, Andre and Bell, Scott (2024). Nontuberculous mycobacteria (NTM) in Australians with cystic fibrosis (CF): A national study. 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD, Australia, 2–4 August 2024. Richmond, VIC, Australia: John Wiley & Sons. |
2023 Journal Article In vitro susceptibility testing of imipenem- relebactam and tedizolid against 102 Mycobacterium abscessus isolatesBurke, Andrew, Carter, Robyn, Tolson, Carla, Congdon, Jacob, Duplancic, Christine, Bursle, Evan, Bell, Scott C., Roberts, Jason A. and Thomson, Rachel (2023). In vitro susceptibility testing of imipenem- relebactam and tedizolid against 102 Mycobacterium abscessus isolates. International Journal of Antimicrobial Agents, 62 (4) 106938, 1-6. doi: 10.1016/j.ijantimicag.2023.106938 |
2023 Journal Article A systematic review of the clinical impact of small colony variants in patients with cystic fibrosisRyan, Harrigan, Ballard, Emma, Stockwell, Rebecca E., Duplancic, Christine, Thomson, Rachel M., Smith, Kimberley and Bell, Scott C. (2023). A systematic review of the clinical impact of small colony variants in patients with cystic fibrosis. BMC Pulmonary Medicine, 23 (1) 323, 1-10. doi: 10.1186/s12890-023-02611-4 |
2023 Conference Publication In vitro susceptibility testing of imipenem- relebactam and tedizolid against australian mycobacterium abscessus isolatesBurke, A. J., Carter, R., Tolson, C., Congdon, J., Duplancic, C., Bursle, E., Bell, S., Roberts, J. and Thomson, R. (2023). In vitro susceptibility testing of imipenem- relebactam and tedizolid against australian mycobacterium abscessus isolates. ATS 2023 International Conference, Washington, DC USA, 19-24 May 2023. Washington, DC USA: American Thoracic Society. doi: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2968 |
2023 Conference Publication Nontuberculous mycobacteria in Australians with cystic fibrosis: A national surveyBell, S., Duplancic, C., Wainwright, C., Thomson, R., Rogers, G., Clements, A. and Floto, R. (2023). Nontuberculous mycobacteria in Australians with cystic fibrosis: A national survey. TSANZSRS 2023 Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science, Christchurch, New Zealand, 25 - 28 March 2023. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/resp.14459 |
2022 Conference Publication Non-tuberculous mycobacteria in Australians with cystic fibrosis: a national surveyDuplancic, C., Wainwright, C., Thomson, R., Rogers, G., Clements, A., Floto, R. and Bell, S. (2022). Non-tuberculous mycobacteria in Australians with cystic fibrosis: a national survey. TSANZSRS 2022 The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ), Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science, virtual, 31 March-2 April 2022. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/resp.14216 |
2021 Journal Article Emergence and impact of oprD mutations in Pseudomonas aeruginosa strains in cystic fibrosisSherrard, Laura J., Wee, Bryan A., Duplancic, Christine, Ramsay, Kay A., Dave, Keyur A., Ballard, Emma, Wainwright, Claire E., Grimwood, Keith, Sidjabat, Hanna E., Whiley, David M., Beatson, Scott A., Kidd, Timothy J. and Bell, Scott C. (2021). Emergence and impact of oprD mutations in Pseudomonas aeruginosa strains in cystic fibrosis. Journal of Cystic Fibrosis, 21 (1), e35-e43. doi: 10.1016/j.jcf.2021.03.007 |
2020 Journal Article All major cholesterol-dependent cytolysins use glycans as cellular receptorsShewell, Lucy K., Day, Christopher J., Jen, Freda E.-C., Haselhorst, Thomas, Atack, John M., Reijneveld, Josephine F., Everest-Dass, Arun, James, David B. A., Boguslawski, Kristina M., Brouwer, Stephan, Gillen, Christine M., Luo, Zhenyao, Kobe, Bostjan, Nizet, Victor, von Itzstein, Mark, Walker, Mark J., Paton, Adrienne W., Paton, James C., Torres, Victor J. and Jennings, Michael P. (2020). All major cholesterol-dependent cytolysins use glycans as cellular receptors. Science Advances, 6 (21) EAAZ4926, eaaz4926. doi: 10.1126/sciadv.aaz4926 |
2019 Conference Publication High incidence of non-tuberculous mycobacteria-positive cultures among children with cystic fibrosis in AustraliaDuplancic, C., Thomson, R., Wainwright, C. and Bell, S. C. (2019). High incidence of non-tuberculous mycobacteria-positive cultures among children with cystic fibrosis in Australia. 33rd Annual North American Cystic Fibrosis Conference, Nashville, TN United States, 31 October – 2 November 2019. Hoboken, NJ United States: John Wiley & Sons. |
2019 Journal Article Multi-centre ethics and research governance review can impede non-interventional clinical researchDuplancic, Christine, Crough, Tania, Bell, Scott C., Australian NTM in CF Study Group and Thomson, Rachel (2019). Multi-centre ethics and research governance review can impede non-interventional clinical research. Internal Medicine Journal, 49 (6), 722-728. doi: 10.1111/imj.14158 |
2019 Conference Publication Non-tuberculous mycobacteria infection in people with cystic fibrosis attending cf treatment clinics in AustraliaDuplancic, C., Wainwright, C., Thomson, R. and Bell, S. (2019). Non-tuberculous mycobacteria infection in people with cystic fibrosis attending cf treatment clinics in Australia. TSANZ, Gold Coast, QLD, Australia, 29 March-2 April 2019. Hoboken, NJ, United States: John Wiley & Sons. |
2019 Journal Article A controlled human infection model of Group A Streptococcus pharyngitis: which strain and why?Osowicki, Joshua, Azzopardi, Kristy I., McIntyre, Liam, Rivera-Hernandez, Tania, Ong, Cheryl-Lynn Y., Baker, Ciara, Gillen, Christine M., Walker, Mark J., Smeesters, Pierre R., Davies, Mark R. and Steer, Andrew C. (2019). A controlled human infection model of Group A Streptococcus pharyngitis: which strain and why?. mSphere, 4 (1) e00647-18, e00647-18. doi: 10.1128/mSphere.00647-18 |
2018 Journal Article Face Masks Reduce the Release of Pseudomonas aeruginosa Cough Aerosols when Worn for Clinically-Relevant Time PeriodsStockwell, Rebecca E., Wood, Michelle E., He, Congrong, Sherrard, Laura J., Ballard, Emma L., Kidd, Timothy J., Johnson, Graham R., Knibbs, Luke D., Morawska, Lidia, Bell, Scott C., CF Cough Aerosol Group and Duplancic, Christine (2018). Face Masks Reduce the Release of Pseudomonas aeruginosa Cough Aerosols when Worn for Clinically-Relevant Time Periods. American Journal of Respiratory and Critical Care Medicine, 198 (10) rccm.201805-0823LE, 1339-1342. doi: 10.1164/rccm.201805-0823LE |
2017 Journal Article Linoleic and palmitoleic acid block streptokinase-mediated plasminogen activation and reduce severity of invasive group A streptococcal infectionRox, Katharina, Jansen, Rolf, Loof, Torsten G., Gillen, Christine M., Bernecker, Steffen, Walker, Mark J., Chhatwal, Gursharan Singh and Müller, Rolf (2017). Linoleic and palmitoleic acid block streptokinase-mediated plasminogen activation and reduce severity of invasive group A streptococcal infection. Scientific Reports, 7 (1) 11798, 1-12. doi: 10.1038/s41598-017-11276-z |
2016 Journal Article Streptococcus iniae cpsG alters capsular carbohydrate composition and is a cause of serotype switching in vaccinated fishHeath, Candice, Gillen, Christine M., Chrysanthopoulos, Panagiotis, Walker, Mark J. and Barnes, Andrew C. (2016). Streptococcus iniae cpsG alters capsular carbohydrate composition and is a cause of serotype switching in vaccinated fish. Veterinary Microbiology, 193, 116-124. doi: 10.1016/j.vetmic.2016.08.011 |
2016 Journal Article Differing efficacies of lead Group A Streptococcal vaccine candidates and full-length M protein in cutaneous and invasive disease modelsRivera-Hernandez, Tania, Pandey, Manisha, Henningham, Anna, Cole, Jason, Choudhury, Biswa, Cork, Amanda J., Gillen, Christine M., Ghaffar, Khairunnisa Abdul, West, Nicholas P., Silvestri, Guido, Good, Michael F., Moyle, Peter M., Toth, Istvan, Nizet, Victor, Batzloff, Michael R. and Walker, Mark J. (2016). Differing efficacies of lead Group A Streptococcal vaccine candidates and full-length M protein in cutaneous and invasive disease models. mBio, 7 (3) e00618-16, e00618-16.1-e00618-16.9. doi: 10.1128/mBio.00618-16 |
2015 Journal Article Manganese homeostasis in group A Streptococcus is critical for resistance to oxidative stress and virulenceTurner, Andrew G., Ong, Cheryl-lynn, Gillen, Christine M., Davies, Mark R., West, Nicholas P., McEwan, Alastair G. and Walker, Mark J. (2015). Manganese homeostasis in group A Streptococcus is critical for resistance to oxidative stress and virulence. mBio, 6 (2) e00278-15, 1-10. doi: 10.1128/mBio.00278-15 |
2014 Journal Article The cholesterol-dependent cytolysins pneumolysin and streptolysin O require binding to red blood cell glycans for hemolytic activity.Shewell, Lucy K., Harvey,Richard M., Higgins, Melanie A., Day, Christopher J., Hartley-Tassell, Lauren E., Chen, Austen Y., Gillen, Christine M., James, David B. A., Alonzo, Francis, Torres, Victor J., Walker, Mark J., Paton, Adrienne W., Paton, James C. and Jennings, Michael P. (2014). The cholesterol-dependent cytolysins pneumolysin and streptolysin O require binding to red blood cell glycans for hemolytic activity.. Proceedings of the National Academy of Sciences of the United State of America, 111 (49), E5312-E5320. doi: 10.1073/pnas.1412703111 |
2014 Journal Article An antimicrobial role for zinc in innate immune defence against group A streptococcusOng, Cheryl-lynn Y., Gillen, Christine M., Barnett, Timothy C., Walker, Mark J. and McEwan, Alastair G. (2014). An antimicrobial role for zinc in innate immune defence against group A streptococcus. Journal of Infectious Diseases, 209 (10), 1500-1508. doi: 10.1093/infdis/jiu053 |
2014 Journal Article Disease manifestations and pathogenic mechanisms of group A StreptococcusWalker, Mark J., Barnett, Timothy C., McArthur, Jason D., Cole, Jason N., Gillen, Christine M., Henningham, Anna, Sriprakash, K. S., Sanderson-Smith, Martina L. and Nizet, Victor (2014). Disease manifestations and pathogenic mechanisms of group A Streptococcus. Clinical Microbiology Reviews, 27 (2), 264-301. doi: 10.1128/CMR.00101-13 |